Runzhe Chen

P.R. China
China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications

Expression of the SAR2-Cov-2 receptor ACE2 reveals the susceptibility of COVID-19 in non-small cell lung cancer.

Expression of the SAR2-Cov-2 receptor ACE2 reveals the susceptibility of COVID-19 in non-small cell lung cancer.

Journal: Journal of Cancer
Published: June 13, 2020

Lobaplatin-Induced Apoptosis Requires p53-Mediated p38MAPK Activation Through ROS Generation in Non-Small-Cell Lung Cancer.

Lobaplatin-Induced Apoptosis Requires p53-Mediated p38MAPK Activation Through ROS Generation in Non-Small-Cell Lung Cancer.

Journal: Frontiers in oncology
Published: April 09, 2019

Treatment and prognostic factors for survival in newly diagnosed multiple myeloma patients with bortezomib and dexamethasone regimen: a single Chinese center retrospective study.

Treatment and prognostic factors for survival in newly diagnosed multiple myeloma patients with bortezomib and dexamethasone regimen: a single Chinese center retrospective study.

Journal: Cancer management and research
Published: September 09, 2017

Efficacy of carfilzomib in the treatment of relapsed and (or) refractory multiple myeloma: a meta-analysis of data from clinical trials.

Efficacy of carfilzomib in the treatment of relapsed and (or) refractory multiple myeloma: a meta-analysis of data from clinical trials.

Journal: Discovery medicine
Published: November 23, 2016

Effect of pomalidomide on relapsed/refractory multiple myeloma: a systematic review and meta-analysis.

Effect of pomalidomide on relapsed/refractory multiple myeloma: a systematic review and meta-analysis.

Journal: Journal of Cancer
Published: October 19, 2016

Gambogenic acid synergistically potentiates bortezomib-induced apoptosis in multiple myeloma.

Gambogenic acid synergistically potentiates bortezomib-induced apoptosis in multiple myeloma.

Journal: Journal of Cancer
Published: September 21, 2016

Lobaplatin for the treatment of SK-MES-1 lung squamous cell line in vitro and in vivo.

Lobaplatin for the treatment of SK-MES-1 lung squamous cell line in vitro and in vivo.

Journal: OncoTargets and therapy
Published: July 30, 2016

CD19 chimeric antigen receptor T cell therapy for the treatment of B cell lineage acute lymphoblastic leukemia.

CD19 chimeric antigen receptor T cell therapy for the treatment of B cell lineage acute lymphoblastic leukemia.

Journal: Discovery medicine
Published: November 13, 2015

Siltuximab (CNTO 328): a promising option for human malignancies.

Siltuximab (CNTO 328): a promising option for human malignancies.

Journal: Drug design, development and therapy
Published: July 15, 2015

Umbilical cord blood transplantation supplemented with the infusion of mesenchymal stem cell for an adolescent patient with severe aplastic anemia: a case report and review of literature.

Umbilical cord blood transplantation supplemented with the infusion of mesenchymal stem cell for an adolescent patient with severe aplastic anemia: a case report and review of literature.

Journal: Patient preference and adherence
Published: June 20, 2015

Severe thrombocytopenia after dasatinib treatment in a patient with Philadelphia chromosome-positive chronic myeloid leukemia.

Severe thrombocytopenia after dasatinib treatment in a patient with Philadelphia chromosome-positive chronic myeloid leukemia.

Journal: OncoTargets and therapy
Published: May 12, 2015

Brentuximab vedotin for treatment of relapsed or refractory malignant lymphoma: results of a systematic review and meta-analysis of prospective studies.

Brentuximab vedotin for treatment of relapsed or refractory malignant lymphoma: results of a systematic review and meta-analysis of prospective studies.

Journal: Drug design, development and therapy
Published: May 07, 2015
Showing 1-12 of 19

Last Updated: 09/26/2026